Synthesis and oxidant properties of novel (5-bromobenzofuran-2-yl) (3-methyl-3-mesitylcyclobutyl)ketonethiosemicarbazone

dc.contributor.authorKaratas, Fikret
dc.contributor.authorKoca, Murat
dc.contributor.authorKara, Haki
dc.contributor.authorServi, Suleyman
dc.date.accessioned2026-08-12T17:44:34Z
dc.date.issued2006
dc.departmentFırat Üniversitesi
dc.description.abstractThe reaction of 5-bromosalicylaldehyde with 1-mesityl-1-methyl-3-(2-chloro-1-oxoethyl)cyclobutane (1) and potassium carbonate was used to prepare (5-bromobenzofuran-2-yl)(3-methyl-3-mesitylcyclobutyl)methanone (2) for the starting reagent purposes. (5-Bromobenzofuran-2-yl)(3-methyl-3-mesitylcyclobutyl)ketonethiosemicarbazone (3) was synthesized from the reaction of the compound (2) with thiosemicarbazide. In the present study, it was aimed to examine the influence of synthetic (5-bromobenzofuran-2-yl)(3-methyl-3-mesityl cyclobutyl)ketonethiosemicarbazone on levels of vitamins (A, E, C), selenium and malondialdehyde in rats. A total of 42 rats were used and the animals were divided into two groups in the study. Only a subcutaneous injection of 250 mu l of 75% ethanol was given to the control group every other day. A subcutaneous injection of this compound (25 mg kg(-1), dissolved in 250 mu l of 75% ethanol) was administered to the other group of rats. After the application of (5-bromobenzofuran-2-yl)(3-methyl-3-mesitylcyclobutyl)ketonethiosemicarbazone for 20 days, the serum vitamins (A, E, C) and malondialdehyde levels were determined with high performance liquid chromatography, the serum selenium level was determined by using fluorescence spectrophotometer. The serum vitamin A, E, C and selenium levels were significantly decreased compared to control group (P < 0.005), whereas serum malondialdehyde levels were higher than control group levels (P < 0.005). As a result, it could be suggested that this compound induced a severe stress, and also increased the amount of free radicals depending on the stress. (c) 2006 Elsevier SAS. All rights reserved.
dc.identifier.doi10.1016/j.ejmech.2006.01.003
dc.identifier.endpage669
dc.identifier.issn0223-5234
dc.identifier.issn1768-3254
dc.identifier.issue5
dc.identifier.orcid0000-0002-9250-0293
dc.identifier.pmid16527373
dc.identifier.scopus2-s2.0-33646814916
dc.identifier.scopusqualityQ1
dc.identifier.startpage664
dc.identifier.urihttps://doi.org/10.1016/j.ejmech.2006.01.003
dc.identifier.urihttps://hdl.handle.net/11508/60324
dc.identifier.volume41
dc.identifier.wosWOS:000238460300014
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier France-Editions Scientifiques Medicales Elsevier
dc.relation.ispartofEuropean Journal of Medicinal Chemistry
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectthiosemicarbazone-substituted benzofuran
dc.subjectantioxidants
dc.subjectMDA
dc.titleSynthesis and oxidant properties of novel (5-bromobenzofuran-2-yl) (3-methyl-3-mesitylcyclobutyl)ketonethiosemicarbazone
dc.typeArticle

Dosyalar